Disclosures for "Corticosteroid Treatment of Developmental and/or Epileptic Encephalopathy with Spike-wave Activation in Sleep (D/EE-SWAS): A Pediatric Epilepsy Research Consortium (PERC) Survey Study"
-
Dr. Phillips has nothing to disclose.
-
Dr. Adams has nothing to disclose.
-
Dr. Bhatia has nothing to disclose.
-
The institution of Dr. Fine has received research support from Neurocrine Biosciences. The institution of Dr. Fine has received research support from UCB. The institution of Dr. Fine has received research support from American Board of Psychiatry and Neurology.
-
The institution of Dr. Gaillard has received research support from all federal or foundation grants, NINDS, NIDCD, NICHD, NSF ,PERF.
-
Dr. Kelley has received publishing royalties from a publication relating to health care. Dr. Kelley has received personal compensation in the range of $500-$4,999 for serving as a Author with Elsevier. Dr. Kelley has received personal compensation in the range of $5,000-$9,999 for serving as a Speaker with Med Learning Group.
-
Dr. Khalil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ucb.
-
Dr. Liu has nothing to disclose.
-
Dr. McLaren has nothing to disclose.
-
Dr. Rao has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Sutton Pierce. Dr. Rao has stock in Epygenix, Inc. The institution of Dr. Rao has received research support from UCB. The institution of Dr. Rao has received research support from Eisai.
-
Dr. Stowe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurocrine Biosciences. Dr. Stowe has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda Pharmaceuticals. Dr. Stowe has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Kherkher Garcia, LLP.